BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 1650689)

  • 1. Hepatitis C antibody in patients with chronic liver disease and hepatocellular carcinoma.
    Colombo M; Rumi MG; Donato MF; Tommasini MA; Del Ninno E; Ronchi G; Kuo G; Houghton M
    Dig Dis Sci; 1991 Aug; 36(8):1130-3. PubMed ID: 1650689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of hepatitis C virus in chronic hepatitis B virus infection.
    Chuang WL; Chang WY; Lu SN; Lin ZY; Chen SC; Hsieh MY; Wang LY; You SL; Chen CJ
    Gastroenterol Jpn; 1993 May; 28 Suppl 5():23-7. PubMed ID: 7689504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-HCV positive hepatocellular carcinoma in cirrhosis. Prevalence, risk factors and clinical features.
    Farinati F; Fagiuoli S; De Maria N; Chiaramonte M; Aneloni V; Ongaro S; Salvagnini M; Naccarato R
    J Hepatol; 1992 Mar; 14(2-3):183-7. PubMed ID: 1380021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma.
    Kaklamani E; Trichopoulos D; Tzonou A; Zavitsanos X; Koumantaki Y; Hatzakis A; Hsieh CC; Hatziyannis S
    JAMA; 1991 Apr; 265(15):1974-6. PubMed ID: 1848908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of antibody against the core protein of hepatitis C virus in patients with hepatocellular carcinoma.
    Watanabe Y; Harada S; Saito I; Miyamura T
    Int J Cancer; 1991 May; 48(3):340-3. PubMed ID: 1710205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of hepatitis B and C viral markers in Japanese patients with hepatocellular carcinoma.
    Tanaka N; Chiba T; Matsuzaki Y; Osuga T; Aikawa T; Mitamura K
    Gastroenterol Jpn; 1993 Aug; 28(4):547-53. PubMed ID: 7690725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C-related hepatocellular carcinoma. Prevalence and significance.
    Resnick RH; Koff R
    Arch Intern Med; 1993 Jul; 153(14):1672-7. PubMed ID: 7687423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A low prevalence of anti-hepatitis C virus antibody in patients with hepatocellular carcinoma in Guangxi Province, southern China.
    Okuno H; Xie ZC; Lu BY; Qin X; Takasu M; Kano H; Shiozaki Y; Inoue K
    Cancer; 1994 Jan; 73(1):58-62. PubMed ID: 7506119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-HCV antibody in Chinese cirrhotic patients with or without hepatocellular carcinoma: relation to multitransfusion.
    Chang WY; Wang LY; Chuang WL; Chen SC; Lu SN; You SL
    J Gastroenterol Hepatol; 1992; 7(2):128-31. PubMed ID: 1315166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of anti-hepatitis C virus among Chinese patients with hepatocellular carcinoma.
    Lee SD; Lee FY; Wu JC; Hwang SJ; Wang SS; Lo KJ
    Cancer; 1992 Jan; 69(2):342-5. PubMed ID: 1309428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevalence of anti-HCV in sera of patients with hepatocellular carcinoma].
    Yu ZY
    Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):44-6. PubMed ID: 7687532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of hepatitis B and C viruses in hepatocellular carcinoma in a hepatitis B endemic area. A case-control study.
    Chuang WL; Chang WY; Lu SN; Su WP; Lin ZY; Chen SC; Hsieh MY; Wang LY; You SL; Chen CJ
    Cancer; 1992 Apr; 69(8):2052-4. PubMed ID: 1311978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to non-structural hepatitis C virus antigens: a link with liver disease activity?
    Gessoni G; Manoni F
    Eur J Med; 1992 Sep; 1(5):288-94. PubMed ID: 1285245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C--the Malaysian story.
    Sinniah M; Ooi BG
    Singapore Med J; 1993 Apr; 34(2):132-4. PubMed ID: 8266152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus, alcoholic cirrhosis, and hepatocellular carcinoma.
    Goeser T; Müller HM; Solbach C; Toex U; Kommerell B; Theilmann L
    Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):311-5. PubMed ID: 8061579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus infection in hepatocellular carcinoma. Detection of plus-strand and minus-strand viral RNA.
    Takeda S; Shibata M; Morishima T; Harada A; Nakao A; Takagi H; Nagai Y
    Cancer; 1992 Nov; 70(9):2255-9. PubMed ID: 1327494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma) in Japan.
    Tomimatsu M; Ishiguro N; Taniai M; Okuda H; Saito A; Obata H; Yamamoto M; Takasaki K; Nakano M
    Cancer; 1993 Aug; 72(3):683-8. PubMed ID: 8192727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B and C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma: a case-control study.
    Tsai JF; Chang WY; Jeng JE; Ho MS; Lin ZY; Tsai JH
    Liver; 1994 Apr; 14(2):98-102. PubMed ID: 7515142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predominant etiologic association of hepatitis C virus with hepatocellular carcinoma compared with hepatitis B virus in elderly patients in a hepatitis B-endemic area.
    Lee HS; Han CJ; Kim CY
    Cancer; 1993 Nov; 72(9):2564-7. PubMed ID: 8402477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for hepatitis C viral infection in patients with primary hepatocellular carcinoma.
    Tong MJ; Lee SY; Hwang SJ; Co RL; Lai PP; Chien D; Kuo G
    West J Med; 1994 Feb; 160(2):133-8. PubMed ID: 7512778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.